Evidence map›Paper›PMID 28694779›Full record

ArticleFrontiers in pharmacology2017

Embryo and Developmental Toxicity of Cefazolin Sodium Impurities in Zebrafish.

Bo Chen, Zhu-Qing Gao, Ying Liu, Yang-Min Zheng, Ying Han, Jing-Pu Zhang, Chang-Qin Hu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in pharmacology · 2019
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Bo ChenDepartment of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing, China.
Zhu-Qing GaoDivision of Antibiotics, National Institutes for Food and Drug Control, Graduate School of Peking Union Medical CollegeBeijing, China.
Ying LiuDivision of Antibiotics, National Institutes for Food and Drug Control, Graduate School of Peking Union Medical CollegeBeijing, China.
Yang-Min ZhengDepartment of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing, China.
Ying HanDivision of Antibiotics, National Institutes for Food and Drug Control, Graduate School of Peking Union Medical CollegeBeijing, China.
Jing-Pu ZhangDepartment of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing, China.
Chang-Qin HuDivision of Antibiotics, National Institutes for Food and Drug Control, Graduate School of Peking Union Medical CollegeBeijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNNational Institutes for Food and Drug Control · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cefazolin sodium is an essential drug that is widely used in clinical therapy for certain infective diseases caused by bacteria. As drug impurities are considered to be one of the most important causes of drug safety issues, we studied embryotoxicity, cardiotoxicity, and neurotoxicity of nine cefazolin sodium impurities in zebrafish embryo and larvae for the objective control of impurity profiling. LC-MS/MS was employed to analyze the compound absorbance

Indexed as

cefazolinimpuritiesstructure-toxicity correlationtoxicity evaluationzebrafish

Identifiers

PMID28694779
PMCPMC5483477
OpenAlexW2731200706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.